Download Now - The Burrill Report

SEPTEMBER STATISTICSThe Burrill Report❱❱ (continued)September 2012 Venture FinancingsCOMPANYRAISED(USD M)PRINCIPAL FOCUSFINANCINGROUNDINVESTORSSalutaris Medical Devices 1.1 Medical devices Venture debt Not disclosedTissue RegenerationSystems1.0 Tools/Technology Part of $5M offering Not disclosedEchoPixel 1.0 Tools/Technology Part of $2M offering Not disclosedPharmatrophiX 0.8 Therapeutics Debt financing Not disclosedOpsonic Therapeutics 0.8 Therapeutics Venture debt Private investorGI Therapeutics 0.6 Therapeutics Hatteras Venture PartnersKewl Innovations 0.6 Medical devices Equity Not disclosedCytodyn 0.6 Therapeutics Equity only Not disclosedINRange Systmes 0.6 Digital Health Debt only Not disclosedAesRx 0.5 Therapeutics Debt financing Not disclosedLabStyle Innovations 0.5 Tools/Technology Part of $1.5M round Not disclosedCapso Vision 0.5 Medical devices Venture debt Not disclosedAgeneBio 0.5 Therapeutics Venture debt Not disclosedWindmill CardiovascularSystems0.4 Medical devices Equity Not disclosedCardiac Insight 0.3 Digital Health Venture debt Not disclosedSpectraScience 0.3 Medical devices Part of $1.5M round Not disclosedProThera Biologics 0.3 Therapeutics Slater Technology FundBioKier 0.2 Therapeutics Seed stage Not disclosedNasseo 0.2 Tools/Technology Part of $0.308MroundAngel investorsGlySens N/A Digital Health West Health Investment Fund; undisclosed investorsSense4Baby N/A Digital Health Seed stage West Health Investment FundTOTAL U.S VENTUREFINANCINGS 667.9CureVac (Germany) 104.9 Therapeutics Series D dievini Hopp BiotechTriplex InternationalBiosciences (China)F2G Limited (UnitedKingdom)50.0 Diagnostics Private equityinvestmentRRJ Capital (Hong Kong)30.0 Therapeutics Advent Life Sciences; Novartis Bioventures; Sunstone Capital;Merifin Capital; K Nominees; Astellas Venture FundMainstay Medical (Ireland) 20.0 Medical devices Series B Fountain Healthcare Partners; Medtronic; Capricorn VenturePartners; Seventure Partners; Sofinnova Partners; Twin CityAngelsWaterstonePharmaceuticals (China)19.0 Tools/Technology Debt financing Not disclosedTheravectys (France) 9.4 Therapeutics Series C Guy Paillaud; John Pieters; Bettencourt family; Philippe Oddo;Richard Hennessy; other private investorsKarus Therapeutics (UnitedKingdom)7.6 Therapeutics Series B, firsttrancheSV Life Sciences; New Leaf Ventures; Novo A/S; InternationalBiotechnology TrustLaurantis Pharma (Finland) 7.0 Therapeutics Broadview Ventures; Inveni Capital; Aloitusrahasto Vera;Helsinki University Funds; VeritasOxThera (Sweden) 5.9 Therapeutics HealthCap; Industrifonden; Q-Med(continued) ❱❱November 2012 27